Odds ratio (OR) of osteoporosis,a according to self‐reported psoriasis from the third Nord‐Trøndelag Health Study (HUNT3) population of Norwayb
| Osteoporosis in HUNT3 BMD subpopulation (n = 10 784) | Adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | |
| Crude n (%b) | OR (95% CI)b | OR (95% CI)b | OR (95% CI)b | |
| Overall osteoporosisc | ||||
| No psoriasis | 1352 (11) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 82 (10) | 0·77 (0·54–1·10) | 0·74 (0·52–1·07) | 0·81 (0·56–1·18) |
| Women with osteoporosis | ||||
| No psoriasis | 1017 (13) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 61 (12) | 0·91 (0·63–1·31) | 0·83 (0·58–1·19) | 0·92 (0·64–1·33) |
| Men with osteoporosis | ||||
| No psoriasis | 335 (9) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 21 (6) | 0·59 (0·27–1·29) | 0·62 (0·28–1·35) | 0·69 (0·31–1·53) |
| Osteoporosis in HUNT3 BMD subpopulation (n = 10 784) | Adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | |
| Crude n (%b) | OR (95% CI)b | OR (95% CI)b | OR (95% CI)b | |
| Overall osteoporosisc | ||||
| No psoriasis | 1352 (11) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 82 (10) | 0·77 (0·54–1·10) | 0·74 (0·52–1·07) | 0·81 (0·56–1·18) |
| Women with osteoporosis | ||||
| No psoriasis | 1017 (13) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 61 (12) | 0·91 (0·63–1·31) | 0·83 (0·58–1·19) | 0·92 (0·64–1·33) |
| Men with osteoporosis | ||||
| No psoriasis | 335 (9) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 21 (6) | 0·59 (0·27–1·29) | 0·62 (0·28–1·35) | 0·69 (0·31–1·53) |
BMD, bone mineral density; BMI, body mass index; CI, confidence interval. aBMD T‐score ≤ −2·5 total hip, femoral neck or lumbar spine. bWeighted: to obtain estimates representative for the total HUNT3 population, we applied probability weights in the statistical analyses to weight the subpopulation of 10 784 to the total HUNT3 study population of 48 914 individuals. cOverall analyses adjusted for sex.
Odds ratio (OR) of osteoporosis,a according to self‐reported psoriasis from the third Nord‐Trøndelag Health Study (HUNT3) population of Norwayb
| Osteoporosis in HUNT3 BMD subpopulation (n = 10 784) | Adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | |
| Crude n (%b) | OR (95% CI)b | OR (95% CI)b | OR (95% CI)b | |
| Overall osteoporosisc | ||||
| No psoriasis | 1352 (11) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 82 (10) | 0·77 (0·54–1·10) | 0·74 (0·52–1·07) | 0·81 (0·56–1·18) |
| Women with osteoporosis | ||||
| No psoriasis | 1017 (13) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 61 (12) | 0·91 (0·63–1·31) | 0·83 (0·58–1·19) | 0·92 (0·64–1·33) |
| Men with osteoporosis | ||||
| No psoriasis | 335 (9) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 21 (6) | 0·59 (0·27–1·29) | 0·62 (0·28–1·35) | 0·69 (0·31–1·53) |
| Osteoporosis in HUNT3 BMD subpopulation (n = 10 784) | Adjusted for age | Additional adjustment for education, smoking, systemic steroid use | Additional adjustment for BMI | |
| Crude n (%b) | OR (95% CI)b | OR (95% CI)b | OR (95% CI)b | |
| Overall osteoporosisc | ||||
| No psoriasis | 1352 (11) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 82 (10) | 0·77 (0·54–1·10) | 0·74 (0·52–1·07) | 0·81 (0·56–1·18) |
| Women with osteoporosis | ||||
| No psoriasis | 1017 (13) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 61 (12) | 0·91 (0·63–1·31) | 0·83 (0·58–1·19) | 0·92 (0·64–1·33) |
| Men with osteoporosis | ||||
| No psoriasis | 335 (9) | 1·00 (ref.) | 1·00 (ref.) | 1·00 (ref.) |
| Psoriasis | 21 (6) | 0·59 (0·27–1·29) | 0·62 (0·28–1·35) | 0·69 (0·31–1·53) |
BMD, bone mineral density; BMI, body mass index; CI, confidence interval. aBMD T‐score ≤ −2·5 total hip, femoral neck or lumbar spine. bWeighted: to obtain estimates representative for the total HUNT3 population, we applied probability weights in the statistical analyses to weight the subpopulation of 10 784 to the total HUNT3 study population of 48 914 individuals. cOverall analyses adjusted for sex.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
